Morning vs. afternoon: can timing boost cancer immunotherapy?

This study looks at whether getting standard immunotherapy in the morning (before 11 am) or afternoon (after 12 pm) changes how well it fights advanced or metastatic solid tumors. Researchers think the body's internal clock (circadian rhythm) might affect immune activity. About 160 adults with several cancer types will be randomly assigned to morning or afternoon treatment, and the team will track how long the cancer stays under control.